Fortrea and Emery Pharma Partner for Enhanced Rifampin Safety Testing in Clinical Trials
Chicago: Fortrea, a global contract research organisation, has announced a strategic collaboration with Emery Pharma to provide rapid impurity testing of rifampin used in drug-drug interaction (DDI) studies. In a statement, Fortrea said the partnershi…